University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for the federal agency’s Radiation Nuclear Animal Model Development program.
SCOPE: Changing protocol language and site actions are key to making trials inclusive – Pharmaceutical Technology
Share this article The panel at SCOPE discussed tried and tested ways in which trials can be made more inclusive. Image credit: Abigail Beaney/GlobalData Changing